Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure S9. 65 genes classifying early and late acute and convalescent phases on HG-focus platform* Gene symbolGene title p value (Phases) Fold change (early.

Similar presentations


Presentation on theme: "Figure S9. 65 genes classifying early and late acute and convalescent phases on HG-focus platform* Gene symbolGene title p value (Phases) Fold change (early."— Presentation transcript:

1 Figure S9. 65 genes classifying early and late acute and convalescent phases on HG-focus platform* Gene symbolGene title p value (Phases) Fold change (early acute vs convalescent) Fold change (late acute vs convalescent) BIRC5baculoviral IAP repeat-containing 53.19E-411.140033.56459 BUB1budding uninhibited by benzimidazoles 1 homolog (yeast)7.16E-371.25334.73311 CACNA2D3calcium channel, voltage-dependent, alpha 2/delta subunit 33.39E-380.3935140.368638 CCL2chemokine (C-C motif) ligand 24.08E-2915.02941.44789 CCL8chemokine (C-C motif) ligand 88.67E-3320.55221.18127 CCNA2cyclin A28.60E-411.256124.1209 CCNB2cyclin B21.98E-381.244233.97997 CD1CCD1c molecule8.18E-420.4315980.469248 CD38CD38 molecule4.12E-402.930216.48604 CDC20cell division cycle 20 homolog (S. cerevisiae)5.06E-411.20264.40779 CDK1cyclin-dependent kinase 12.29E-371.132283.77973 CDKN1Ccyclin-dependent kinase inhibitor 1C (p57, Kip2)7.95E-292.884010.36381 CDKN3cyclin-dependent kinase inhibitor 32.74E-401.137274.94106 CKS2CDC28 protein kinase regulatory subunit 21.88E-351.569174.32119 CTSL1cathepsin L15.25E-283.567791.06798 CXCL10chemokine (C-X-C motif) ligand 104.31E-2324.11581.88478 EEF1B2eukaryotic translation elongation factor 1 beta 21.13E-330.3748450.847775 FABP5fatty acid binding protein 5 (psoriasis-associated)7.13E-391.179434.37363 FEN1flap structure-specific endonuclease 16.66E-371.087592.75672 GGH gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase)2.34E-291.152654.35809 GINS2GINS complex subunit 2 (Psf2 homolog)8.24E-401.184583.23807 GMNNgeminin, DNA replication inhibitor2.56E-401.40734.70569 HERC5hect domain and RLD 51.80E-349.728651.62272 HESX1HESX homeobox 13.60E-325.174061.28515 HMMRhyaluronan-mediated motility receptor (RHAMM)1.26E-351.136782.9076 IFI27interferon, alpha-inducible protein 27077.471345.6986 IFI44interferon-induced protein 445.12E-315.979432.10563 IFI44Linterferon-induced protein 44-like1.22E-2911.59932.7425 IFIH1interferon induced with helicase C domain 12.80E-306.776741.70868 IFIT1interferon-induced protein with tetratricopeptide repeats 15.94E-2819.86792.25936 IFIT3interferon-induced protein with tetratricopeptide repeats 32.66E-2511.37161.64338 IFITM3interferon induced transmembrane protein 3 (1-8U)8.60E-334.429421.56196 IRF7interferon regulatory factor 77.95E-346.890591.81825 ISG15ISG15 ubiquitin-like modifier1.16E-3712.73792.52757 LAMP3lysosomal-associated membrane protein 31.42E-255.347511.31592 LGALS3BPlectin, galactoside-binding, soluble, 3 binding protein2.35E-315.721531.76915 MCM6minichromosome maintenance complex component 69.54E-371.096553.24522 MS4A4Amembrane-spanning 4-domains, subfamily A, member 47.39E-3011.11691.01111 MT2Ametallothionein 2A7.98E-384.525981.74406 MX1 myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse)4.57E-418.890972.4788 MX2myxovirus (influenza virus) resistance 2 (mouse)4.61E-294.868561.11191 NCAPGnon-SMC condensin I complex, subunit G4.45E-371.109193.50261 NELL2NEL-like 2 (chicken)2.32E-350.2477360.44445 NME1non-metastatic cells 1, protein (NM23A) expressed in5.15E-320.7903392.20392 NUSAP1nucleolar and spindle associated protein 17.81E-411.392325.03253 OAS12',5'-oligoadenylate synthetase 1, 40/46kDa1.06E-367.422841.96153 OAS22'-5'-oligoadenylate synthetase 2, 69/71kDa7.74E-425.172591.93347 OAS32'-5'-oligoadenylate synthetase 3, 100kDa2.27E-327.125691.47893 OASL2'-5'-oligoadenylate synthetase-like1.65E-376.677321.65104 PBKPDZ binding kinase4.42E-321.12513.72316 PCNAproliferating cell nuclear antigen2.53E-391.493973.91554 PLSCR1phospholipid scramblase 18.26E-335.304751.67891 PTTG1pituitary tumor-transforming 12.87E-391.116193.9037 RRM2ribonucleotide reductase M21.40E-451.7692412.3397

2 Figure S9 Continued RTN1reticulon 16.90E-340.4246250.356484 SERPING1serpin peptidase inhibitor, clade G (C1 inhibitor), member 13.33E-3317.70292.44514 SIGLEC1sialic acid binding Ig-like lectin 1, sialoadhesin5.05E-346.013491.62277 STMN1stathmin 17.30E-380.9285952.48741 TNFSF10tumor necrosis factor (ligand) superfamily, member 102.32E-235.991271.28735 TOP2Atopoisomerase (DNA) II alpha 170kDa8.00E-371.178033.71157 TPX2TPX2, microtubule-associated, homolog (Xenopus laevis)1.75E-401.18553.35535 TYMSthymidylate synthetase01.630238.27557 UBE2Cubiquitin-conjugating enzyme E2C6.11E-391.298922.90361 USP18ubiquitin specific peptidase 181.92E-397.536832.22014 ZWINTZW10 interactor2.65E-411.281365.97258 *Symbols in red are phase classifiers found on both the HG-focus and HG-U133plus2 platforms.


Download ppt "Figure S9. 65 genes classifying early and late acute and convalescent phases on HG-focus platform* Gene symbolGene title p value (Phases) Fold change (early."

Similar presentations


Ads by Google